The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia

Journal of the American College of Nutrition

Volumn 23, Issue 5, 2004, Pages 549S-551S

  Nechifor, Mihai ^a   Vaideanu, C ^a   Palamaru, I ^a   Borza, C ^a   Mindreci, I ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Antipsychotic drugs; Cu; Erythrocyte Mg; Haloperidol; Paranoid schizophrenia; Plasma Ca; Plasma Mg; Risperidone; Zn

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; COPPER; HALOPERIDOL; MAGNESIUM; NEUROLEPTIC AGENT; RISPERIDONE; ZINC;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; MALE; MIDDLE AGED; PARANOID SCHIZOPHRENIA; RANDOMIZED CONTROLLED TRIAL; SPECTROPHOTOMETRY;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; CALCIUM; COPPER; ERYTHROCYTES; FEMALE; HALOPERIDOL; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA, PARANOID; SPECTROPHOTOMETRY; ZINC;

EID: 16644394642     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719401     Document Type: Article

References (16)

1. Widmer J, Henrotte JG, Raffin Y, Bovier P, Hilleret H, Gaillard JM: Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J Affective Disorders 34:201–209, 1995.
2. Joffe RT, Levith AJ, Young LT: The thyroid magnesium and calcium in major depression. Biol Psychiatry 40:428–429, 1996.
3. Shane SR, Flink EB: Magnesium deficiency in alcohol addiction and withdrawal. Magnes Trace Elem 10:263–268, 1991.
4. Chugh TD, Dhingra RK, Gulati RC, Bathla JC: Magnesium in schizophrenia. Indian J Med Res 61:998–1001, 1983.
5. Gattaz WF, Kattermann R, Gattaz D, Beckmann H: Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic group. Biol Psychiatry 18: 935–939, 1983.
6. Yassa R, Nair NP, Schwartz G: Plasma magnesium in chronic schizophrenia. A preliminary report. In. Pharmacopsychiatr, 14: 57–64, 1979.
7. Levine J, Rappaport A, Mashiah M, Dolev E: Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients. Neuropsychobiology 33:169-172, 1996.
8. Kirov GK, Tsachev KN: Magnesium in schizophrenia and maniacdepressive disease. Neuropsychobiology 23:89–81, 1990.
9. Kanofsky JD: Magnesium deficiency in chronic schizophrenia. Intl J Neurosci 61:87–90, 1991.
10. Jabotinsky-Rubin K, Durst R, Levitin LA, Moscovich DG, Silver H, Lerner J, Van Praag H, Gardner EL: Effects of haloperidol on human plasma magnesium. J Psychiatr Res 27:155–159, 1993.
11. Olantunbosun DA, Akindele BK, Adadevoh BK, Asuni T: Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:119-121, 1975.
12. Pfeiffer CC, Ilier U: A study of zinc deficiency and copper excess in the schizophrenia. Intl Rev Neurobiol (Suppl) 1:141-165, 1972.
13. Rathbun JK: Neuropsychological aspects of Wilson’s disease. Intl J Neurosci 85:221–229, 1996.
14. Manser WW, Khan MD, Hassan Z: Blood copper, zinc, magnesium and lead level in psychiatric patients with disturbed behaviour. J Pak Med Assoc 39:235–338, 1989.
15. Andrews RC: Unification of the findings in schizophrenia by reference to the effects of gestational zinc deficiency. J Med Hypotheses 31:141–153, 1990.
16. Adams CE, De Masters BK, Freedman R: Regional zinc staining in post-mortem hippocampus from schizophrenic patients. Schizophr Res 18:71–77, 1995.